Literature DB >> 29062252

Plasmapheresis in a child with cold antibody autoimmune hemolytic anemia: case report.

Zeynep Canan Özdemir1, Özcan Bör1, Ener Çağrı Dinleyici2, Eylem Kıral2.   

Abstract

Autoimmune hemolytic anemia is a picture of hemolysis which is caused by autoantibodies against red blood cell surface antigens. It is classified as primary, secondary or warm and cold autoimmune hemolytic anemia according to the temperature at which antibodies react. It is usually an acute and self-limiting condition. Here, we present a three-year-old male patient who presented with malaise, paleness, and dark-colored urine. His hemoglobin level was 5.8 g/dL, and increased indirect bilirubin and lactate dehydrogenase levels and decreased haptoglobulin and reticulocyte levels were noted. A direct Coombs test was positive using anti-C3. Four erythrocyte suspension transfusions were given because the anemia was life-threatening. High-dose steroids (30 mg/kg/ day, methylprednisolone) and intravenous immunoglobulin (1 g/kg/day, two days) treatments were unresponsive. Plasmapheresis was performed and no further transfusions were needed after plasmapheresis. Plasmapheresis treatment can be effective in children with cold type autoimmune hemolytic anemia.

Entities:  

Keywords:  Autoimmune hemolytic anemia; cold antibody; plasmapheresis

Year:  2017        PMID: 29062252      PMCID: PMC5644585          DOI: 10.5152/TurkPediatriArs.2017.2956

Source DB:  PubMed          Journal:  Turk Pediatri Ars


  10 in total

1.  [Fulminant autoimmune cold-type hemolysis with marked elevation of monothermic cold agglutinins. Successful therapy with membrane plasmapheresis].

Authors:  N Gordjani; V Kretschmer; U Töllner; C Rieger
Journal:  Monatsschr Kinderheilkd       Date:  1990-08       Impact factor: 0.323

2.  Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.

Authors:  Zbigniew M Szczepiorkowski; Jeffrey L Winters; Nicholas Bandarenko; Haewon C Kim; Michael L Linenberger; Marisa B Marques; Ravindra Sarode; Joseph Schwartz; Robert Weinstein; Beth H Shaz
Journal:  J Clin Apher       Date:  2010       Impact factor: 2.821

Review 3.  Cold agglutinin disease.

Authors:  Paul L Swiecicki; Livia T Hegerova; Morie A Gertz
Journal:  Blood       Date:  2013-06-11       Impact factor: 22.113

4.  New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children.

Authors:  Nathalie Aladjidi; Guy Leverger; Thierry Leblanc; Marie Quitterie Picat; Gérard Michel; Yves Bertrand; Brigitte Bader-Meunier; Alain Robert; Brigitte Nelken; Virginie Gandemer; Hélène Savel; Jean Louis Stephan; Fanny Fouyssac; Julien Jeanpetit; Caroline Thomas; Pierre Rohrlich; André Baruchel; Alain Fischer; Geneviève Chêne; Y Perel
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

5.  Use of intravenous gamma globulin for the treatment of autoimmune neutropenia of childhood and autoimmune hemolytic anemia.

Authors:  M W Hilgartner; J Bussel
Journal:  Am J Med       Date:  1987-10-23       Impact factor: 4.965

Review 6.  Treatment of autoimmune hemolytic anemias.

Authors:  Alberto Zanella; Wilma Barcellini
Journal:  Haematologica       Date:  2014-10       Impact factor: 9.941

Review 7.  Autoimmune hemolytic anemia.

Authors:  Bradley C Gehrs; Richard C Friedberg
Journal:  Am J Hematol       Date:  2002-04       Impact factor: 10.047

8.  Resolution of severe Donath-Landsteiner autoimmune hemolytic anemia temporally associated with institution of plasmapheresis.

Authors:  Arup Roy-Burman; Bertil E Glader
Journal:  Crit Care Med       Date:  2002-04       Impact factor: 7.598

9.  Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases.

Authors:  J L Liesveld; J M Rowe; M A Lichtman
Journal:  Blood       Date:  1987-03       Impact factor: 22.113

10.  Guidelines on the use of intravenous immune globulin for hematologic conditions.

Authors:  David Anderson; Kaiser Ali; Victor Blanchette; Melissa Brouwers; Stephen Couban; Paula Radmoor; Lothar Huebsch; Heather Hume; Anne McLeod; Ralph Meyer; Catherine Moltzan; Susan Nahirniak; Stephen Nantel; Graham Pineo; Gail Rock
Journal:  Transfus Med Rev       Date:  2007-04
  10 in total
  1 in total

1.  Current treatment options for severe autoimmune hemolytic anemia.

Authors:  Osman Yeşilbaş
Journal:  Turk Pediatri Ars       Date:  2018-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.